{"id":"W1999745497","doi":"10.1111/ijcp.12443","title":"OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder","year":2014,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Allergan","keywords":"Medicine; Overactive bladder; Anticholinergic; Discontinuation; Placebo; Urination; Urology; Urinary incontinence; Tolterodine; Oxybutynin; Trigone of urinary bladder; Adverse effect; Urinary system; Solifenacin; Internal medicine; Anesthesia; Urinary bladder","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002795213,0.0001880683,0.0007033602,0.0001953572,0.00002175322,0.00001837322,0.0004487297,0.000104434,0.00005306576],"category_scores_gemma":[0.003621042,0.0001121314,0.0002059274,0.000270972,0.0002319301,0.0007695168,0.0001568334,0.0006780758,9.695187e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001031006,"about_ca_system_score_gemma":0.000413122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001482534,"about_ca_topic_score_gemma":0.00001117609,"domain_scores_codex":[0.9955674,0.0005975612,0.001881512,0.0002695395,0.001464716,0.0002192184],"domain_scores_gemma":[0.9901045,0.004459053,0.002749077,0.0002770174,0.002323003,0.00008735748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1260083,0.0125257,0.8247164,0.0003660839,0.003691281,0.0001803585,0.001216023,0.0001499475,0.0005404477,0.0006767443,0.00008044429,0.02984826],"study_design_scores_gemma":[0.02038142,0.005370392,0.966911,0.001622146,0.0003118441,0.00004898713,0.00113433,0.0003994876,0.001948194,0.0006636308,0.001060725,0.0001478993],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995276,0.00004329964,0.0003027867,0.002089685,0.0002801859,0.0009679131,0.00003167736,0.000002309087,0.001006186],"genre_scores_gemma":[0.9958221,0.0003104109,0.003303365,0.0001808469,0.0001083194,0.00001938154,0.000007152236,0.00002412155,0.0002242429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1421945,"threshold_uncertainty_score":0.4572585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03376758209583948,"score_gpt":0.4141585933161128,"score_spread":0.3803910112202734,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}